Refresh

Eupharma Laboratories Ltd. - Research Center

530409 EUPHARMLAB Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 03 Mar ' 02 Jun ' 00
Income

Operating income

2.42 2.74 31.16
Expenses

Material consumed

1.86 2.57 29.37

Manufacturing expenses

0.28 0.48 0.35

Personnel expenses

0.29 0.54 0.41

Selling expenses

- - 0.14

Adminstrative expenses

2.65 56.34 0.84

Expenses capitalised

- - -

Cost of sales

5.08 59.93 31.11

Operating profit

-2.66 -57.19 0.06

Other recurring income

1.50 1.03 0.19

Adjusted PBDIT

-1.16 -56.16 0.25

Financial expenses

0.01 0.07 0.24

Depreciation

0.98 1.11 1.18

Other write offs

- - -

Adjusted PBT

-2.15 -57.34 -1.18

Tax charges

- - -

Adjusted PAT

- -57.34 -1.18

Non recurring items

- - 0.60

Other non cash adjustments

- - -0.34

Reported net profit

-2.15 -57.34 -0.92

Earnigs before appropriation

-2.15 -57.34 8.27

Equity dividend

- - -

Preference dividend

- - -

Dividend tax

- - -

Retained earnings

-2.15 -57.34 8.27
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com